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A 49-year-old woman was admitted with chronic renal failure.
Her previous history included poor vision, with photophobia at
3 years; retinitis pigmentosa resulting in legal blindness by age
40; sensorineural hearing loss by age 20 progressing to deafness.
By the age of 27, she developed congestive heart failure;
echocardiography showed dilated cardiomyopathy. Myocardial
biopsy showed interstitial fibrosis and myocellular hypertrophy
(Figure 1). Chronic renal failure (serum creatinine 1.5mg/dl)
was found with negative urinalysis. At the age of 42, insulin
resistance was first documented.
At admission, her weight was 63kg, height 145 cm, body mass
index 30kg/m2. She had normal intelligence. Serum creatinine
was 1.6mg/dl; creatinine clearance 38ml/min; urinalysis negative;
urinary osmolality 360mosmol/kg. Ultrasonography revealed
small kidneys with a few bilateral cysts. Renal biopsy showed
interstitial fibrosis, tubular atrophy (Figure 2).
Family characterization (Figure 3) revealed unaffected
parents, a phenotypically normal sister, and a brother who
died at 1 year from congenital heart disease. A 43-year-old
brother had retinitis pigmentosa, sensorineural deafness,
hepatic fibrosis, adult-onset dilated cardiomyopathy, chronic
renal failure (serum creatinine 1.4mg/dl; creatinine clearance
55ml/min) with negative urinalysis, small kidneys and
hepato-splenic enlargement by ultrasound. Liver rigidity,
measured by transient elastography (Fibroscan, Echosens,
Paris, France), was significantly increased.
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Figure 1 | Endomyocardial biopsy showing severe interstitial
fibrosis and moderate myocellular hypertrophy (hematoxylin
and eosin; original magnification  20).
Figure 2 |Renal biopsy showing focal areas of interstitial
fibrosis and tubular atrophy and normal glomeruli










































Figure 3 |Haplotype of kindred surrounding the ALMS1 region.
Arrow indicates the index case. Males and females are indicated by
squares and circles, respectively; blackened circles and squares
represent affected individuals; gray shading indicates a possible
case of Alstro¨m syndrome with infantile congestive heart failure, but
no other genetic or clinical information is available. Slash indicates
deceased individuals from whom DNA was not available. Both
affected individuals share a common haplotype defined by markers
16770, D2S210, D2S1394, D2S2111, D2S2109, and D2S286.
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The Diagnosis | Alstro¨m syndrome, a rare ciliopathy
with tubulointerstitial renal
involvement
The complex spectrum of phenotypes of our patients is
consistent with those described for ciliopathies, which are
genetic disorders resulting from dysfunction of cilia usually
involving the kidneys.1 The combination of tubulointerstitial
nephritis, retinitis pigmentosa, and liver fibrosis can be
observed in nephronophthisis, a ciliopathy causing the most
frequent hereditary tubulointerstitial nephritis.2 However,
metabolic abnormalities are not typical features of nephro-
nophthisis, whereas they are part of the clinical spectrum of
two pleiotropic ciliopathies, Bardet–Biedl (BBS) and Alstro¨m
syndrome (ALMS).1 Mutational analysis of the known
variants in BBS 1-12 genes (microarray analysis; Asper
Biotech, Tartu, Estonia) did not reveal mutations. Sequencing
analysis of all exons of the ALMS1 gene revealed, in both
affected individuals, a heterozygous frameshift mutation
(S524fsX535) inherited from the mother. Haplotype analysis
found identical haplotypes in the 2p13 ALMS1 region in the
two sibs (Figure 3).
ALMS is a rare recessive ciliopathy caused by mutations in
ALMS1, a novel gene of unknown function. The major
phenotypes are observed in young children; other phenotypes
emerge as the child develops. The diagnosis of ALMS
relies primarily on clinical findings and can be proven by
molecular testing when two mutations are identified. However,
two disease-causing mutations are not easily identified,
suggesting that some patients can harbor mutations in the
promoter/intronic regions.3–5 To help clinicians in making the
diagnosis, a set of age-related diagnostic criteria have been
proposed.5
Our patients fulfilled the diagnostic criteria for adult
ALMS, showing a combination of two major criteria (retinitis
pigmentosa and ALMS1 mutation in a single allele) and at
least four minor criteria (sensorineural hearing loss, hepatic
fibrosis, dilated cardiomyopathy, and renal disease).
Renal disease develops with age in all individuals with
ALMS. Onset occurs in early adolescence/adulthood,
with polyuria and polydipsia. Renal insufficiency leading to
end-stage renal disease occurs in 50% of patients. Histo-
pathological changes include interstitial fibrosis and tubular
atrophy. Similar fibrotic infiltrations underlie many of the
other clinical phenotypes, particularly cardiac, pulmonary,
and hepatic disease, suggesting common pathogenic mechan-
isms.3–5 The mechanisms of the induction of fibrosis
are unknown. Further insights into the function of the
ALMS1 protein will contribute to elucidate this process,
increasing the knowledge of molecular mechanisms involved
in fibrogenesis.
Tubulointerstitial nephritis due to ALMS is a challenging
diagnosis. A high index of suspicion should be maintained in
patients presenting with familial recessive tubulointerstitial
renal disease, retinal degeneration, and sensorineural hearing
loss. The presence of hepatic, cardiac involvement, and
metabolic abnormalities should raise the level of suspicion.
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